STC 1010 companion test - Brenus Pharma
Alternative Names: STC 1010 X companion test - Brenus PharmaLatest Information Update: 28 Sep 2025
At a glance
- Originator Brenus Pharma
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Colorectal cancer; Gastrointestinal cancer; Pancreatic cancer
Most Recent Events
- 28 Sep 2025 No recent reports of development identified for preclinical development in Colorectal-cancer(Diagnosis) in France
- 28 Sep 2025 No recent reports of development identified for preclinical development in Gastrointestinal-cancer(Diagnosis) in France
- 28 Sep 2025 No recent reports of development identified for preclinical development in Pancreatic-cancer(Diagnosis) in France